Copyright © 2014 Ibrahim M. Zardawi. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. A. Riskai, A. Leminen, and E. Pukkala, “Sociodemographic determinants of incidence of primary fallopian tube carcinoma, Finland 1953–97,” International Journal of Cancer, vol. 104, no. 5, pp. 643–645, 2003. View at Publisher · View at Google Scholar · View at Scopus
2. D. Pectasides, E. Pectasides, and T. Economopoulos, “Fallopian tube carcinoma: a review,” The Oncologist, vol. 11, no. 8, pp. 902–912, 2006. View at Publisher · View at Google Scholar · View at Scopus
3. H. Y. Lau, Y. J. Chen, M. S. Yen, R. F. Chen, S. O. Yeh, and N. F. Twu, “Primary fallopian tube carcinoma: a clinicopathologic analysis and literature review,” Journal of the Chinese Medical Association, vol. 76, no. 10, pp. 583–587, 2013. View at Publisher · View at Google Scholar
4. A. Riska, R. Sund, E. Pukkala, M. Gissler, and A. Leminen, “Parity, tubal sterilization, hysterectomy and risk of primary fallopian tube carcinoma in Finland, 1975–2004,” International Journal of Cancer, vol. 120, no. 6, pp. 1351–1354, 2007. View at Publisher · View at Google Scholar · View at Scopus
5. D. Vicus, A. Finch, B. Rosen et al., “Risk factors for carcinoma of the fallopian tube in women with and without a germline BRCA mutation,” Gynecologic Oncology, vol. 118, no. 2, pp. 155–159, 2010. View at Publisher · View at Google Scholar · View at Scopus
6. S. J. Jordan, A. C. Green, D. C. Whiteman et al., “Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiological analysis,” International Journal of Cancer, vol. 122, no. 7, pp. 1598–1603, 2008. View at Publisher · View at Google Scholar · View at Scopus
7. A. Riska, J. I. Martinsen, K. Kjaerheim et al., “Occupation and risk of primary Fallopian tube carcinoma in Nordic countries,” International Journal of Cancer, vol. 131, no. 1, pp. 186–192, 2012. View at Publisher · View at Google Scholar · View at Scopus
8. Australian Bureau of Statistics, “Australian demographic statistics,” Cat. No. 3101.0, 2011. View at Google Scholar
9. M. M. Madeleine, T. Anttila, S. M. Schwartz et al., “Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors,” International Journal of Cancer, vol. 120, no. 3, pp. 650–655, 2007. View at Publisher · View at Google Scholar · View at Scopus
10. M. Ponzoni, A. J. M. Ferreri, M. Guidoboni et al., “Chlamydia infection and lymphomas: association beyond ocular adnexal lymphomas highlighted by multiple detection methods,” Clinical Cancer Research, vol. 14, no. 18, pp. 5794–5800, 2008. View at Publisher · View at Google Scholar · View at Scopus
11. F. A. Tavassoli and P. Devilee, Eds., WHO Classification of Tumours: Pathology and Genetics of Tumours of the Breast and Female Genital Organs, IARC Press, Lyon, France, 2003.
12. L. Dubeau and R. Drapkin, “Coming into focus: the non-ovarian origins of ovarian cancer,” Annals of Oncology, vol. 24, supplement 8, pp. viii28–viii35, 2013. View at Publisher · View at Google Scholar
13. D. W. Kindelberger, Y. Lee, A. Miron et al., “Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship,” The American Journal of Surgical Pathology, vol. 31, no. 2, pp. 161–169, 2007. View at Publisher · View at Google Scholar · View at Scopus
14. Y. Lee, F. Medeiros, D. Kindelberger, M. J. Callahan, M. G. Muto, and C. P. Crum, “Advances in the recognition of tubal intraepithelial carcinoma: applications to cancer screening and the pathogenesis of ovarian cancer,” Advances in Anatomic Pathology, vol. 13, no. 1, pp. 1–7, 2006. View at Publisher · View at Google Scholar · View at Scopus
15. F. Medeiros, M. G. Muto, Y. Lee et al., “The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome,” The American Journal of Surgical Pathology, vol. 30, no. 2, pp. 230–236, 2006. View at Publisher · View at Google Scholar · View at Scopus
16. R. J. Kurman, R. Vang, J. Junge, C. G. Hannibal, S. K. Kjaer, and I.-M. Shih, “Papillary tubal hyperplasia: the putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis,” The American Journal of Surgical Pathology, vol. 35, no. 11, pp. 1605–1614, 2011. View at Publisher · View at Google Scholar · View at Scopus
17. G. L. Hold and E. M. El-Omar, “Genetic aspects of inflammation and cancer,” Biochemical Journal, vol. 410, no. 2, pp. 225–235, 2008. View at Publisher · View at Google Scholar · View at Scopus
18. H.-W. Lin, Y.-Y. Tu, S. Y. Lin et al., “Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study,” The Lancet Oncology, vol. 12, no. 9, pp. 900–904, 2011. View at Publisher · View at Google Scholar · View at Scopus
19. C. B. Rasmussen, M. T. Faber, A. Jensen et al., “Pelvic inflammatory disease and risk of invasive ovarian cancer and ovarian borderline tumors,” Cancer Causes Control, vol. 24, no. 7, pp. 1459–1464, 2013. View at Publisher · View at Google Scholar
20. J. Skapinyecz, I. Smid, A. Horváth, C. Jeney, L. Kardos, and P. Kovács, “Pelvic inflammatory disease is a risk factor for cervical cancer,” European Journal of Gynaecological Oncology, vol. 24, pp. 401–404, 2003. View at Google Scholar
21. J. P. Carvalho and F. M. Carvalho, “Is Chlamydia-infected tubal fimbria the origin of ovarian cancer?” Medical Hypotheses, vol. 71, pp. 690–693, 2008. View at Publisher · View at Google Scholar
22. R. B. Ness, M. T. Goodman, C. Shen, and R. C. Brunham, “Serologic evidence of past infection with Chlamydia trachomatis, in relation to ovarian cancer,” Journal of Infectious Diseases, vol. 187, no. 7, pp. 1147–1152, 2003. View at Publisher · View at Google Scholar · View at Scopus
23. Australian Bureau of Statistics, May 2013, www.abs.gov.au.
24. V. Verma, D. Shen, P. C. Sieving, and C.-C. Chan, “The role of infectious agents in the etiology of ocular adnexal neoplasia,” Survey of Ophthalmology, vol. 53, no. 4, pp. 312–331, 2008. View at Publisher · View at Google Scholar · View at Scopus
25. A. Ruiz, U. Reischl, S. H. Swerdlow et al., “Extranodal marginal zone B-cell lymphomas of the ocular adnexa: multiparameter analysis of 34 cases including interphase molecular cytogenetics and PCR for Chlamydia psittaci,” The American Journal of Surgical Pathology, vol. 31, no. 5, pp. 792–802, 2007. View at Publisher · View at Google Scholar · View at Scopus